Partnership Opportunities

Partner With Us

Are you committed to contributing to the second golden age of GPCR drug discovery?

Can you help biopharma overcome some of the biggest therapeutic challenges facing the field today with commitment to quality and scientific excellence?

If so, the GPCRs – Targeted Drug Discovery Summit is your premium opportunity to showcase your expertise, advance your brand, and benchmark yourself as a key thought leader and solution provider within the community.

We partner with leading and most innovative service providers with capabilities in drug discovery, cellular assay systems, high throughput target screening, structural imaging, bioinformatics, manufacturing, CROs and many more!

If you have expertise in this space and would like to align your brand within the GPCR drug discovery space, contact us to promote your capabilities through a bespoke commercial package. Email sponsor@hansonwade.com to request more information.

Join us on a global platform to benchmark yourself as a key thought leader and demonstrate how your business can empower drug developers and leading experts who are looking for services and solutions to facilitate their R&D platforms to unleash the potential of next-generation of GPCR targets.

Whether you need to communicate exciting progress to the decision makers in the field, are looking to generate leads, or would like to understand what next generation investments the market wants, you can rely on our ability to advise and deliver the right platform for you.

Why Partner?

Benefit from Market Intelligence

Meet & Network with Industry Pioneers

Position Yourself as an Industry Expert

Raise your Brand Awareness

Generate Commercial Collaborations

New drug discovery opportunities in undrugged and orphaned GPCRs opens tremendous opportunity to address the current unmet clinical need. Hear how and where pharmaceutical giants are looking for services and solutions to facilitate their R&D platforms and match your solutions accordingly

With a “room” full of drug developers looking to see how they can effectively translate their exciting early discovery efforts into safe and effective therapeutics, meet prospective clients during structured networking breaks, bespoke 1-2-1 meetings and more informal networking receptions

With the emergence of biotech companies focused on developing GPCR - targeted drug therapeutics, followed by interest shown from large pharma and investors, this meeting is a dedicated platform to put your independent expertise in front of the key decision-makers in the field

Benefit from pre and post-conference exposure to our drug discovery KOL community and increase market share through unique branding formats. Also, differentiate your discovery, preclinical and translational services from other solution providers

Make sure your hottest prospects are in the room and part of the discussion by having a wish-list of your choice contacted in advance of the event